JPWO2023132372A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023132372A5
JPWO2023132372A5 JP2023572498A JP2023572498A JPWO2023132372A5 JP WO2023132372 A5 JPWO2023132372 A5 JP WO2023132372A5 JP 2023572498 A JP2023572498 A JP 2023572498A JP 2023572498 A JP2023572498 A JP 2023572498A JP WO2023132372 A5 JPWO2023132372 A5 JP WO2023132372A5
Authority
JP
Japan
Prior art keywords
delete
concentration
functional food
bonito
food according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023572498A
Other languages
English (en)
Japanese (ja)
Other versions
JP7646137B2 (ja
JPWO2023132372A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/000272 external-priority patent/WO2023132372A1/ja
Publication of JPWO2023132372A1 publication Critical patent/JPWO2023132372A1/ja
Publication of JPWO2023132372A5 publication Critical patent/JPWO2023132372A5/ja
Priority to JP2025026309A priority Critical patent/JP2025081566A/ja
Application granted granted Critical
Publication of JP7646137B2 publication Critical patent/JP7646137B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023572498A 2022-01-07 2023-01-10 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品 Active JP7646137B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025026309A JP2025081566A (ja) 2022-01-07 2025-02-21 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263266531P 2022-01-07 2022-01-07
US63/266,531 2022-01-07
PCT/JP2023/000272 WO2023132372A1 (ja) 2022-01-07 2023-01-10 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025026309A Division JP2025081566A (ja) 2022-01-07 2025-02-21 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Publications (3)

Publication Number Publication Date
JPWO2023132372A1 JPWO2023132372A1 (https=) 2023-07-13
JPWO2023132372A5 true JPWO2023132372A5 (https=) 2024-08-09
JP7646137B2 JP7646137B2 (ja) 2025-03-17

Family

ID=87073805

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023572498A Active JP7646137B2 (ja) 2022-01-07 2023-01-10 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品
JP2025026309A Pending JP2025081566A (ja) 2022-01-07 2025-02-21 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025026309A Pending JP2025081566A (ja) 2022-01-07 2025-02-21 精神神経疾患を予防または改善するための鰹由来抽出物を含む機能性食品

Country Status (3)

Country Link
US (1) US20250057890A1 (https=)
JP (2) JP7646137B2 (https=)
WO (1) WO2023132372A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692784B1 (fr) * 1992-06-24 1995-06-30 Pf Medicament Utilisation de la guanosine, de ses precurseurs et ses derives pour la fabrication de medicaments destines a traiter les deficits fonctionnels cerebraux.
US20010053763A1 (en) * 1998-12-02 2001-12-20 Andrew Salzman Method and composition for modulating an immune response
WO2017068805A1 (ja) * 2015-10-22 2017-04-27 ライオン株式会社 唾液分泌促進剤、これを含有する口腔用組成物及び飲料用組成物
JP6867142B2 (ja) * 2016-11-17 2021-04-28 株式会社スタージェン パーキンソン症状改善用医薬
JP6966840B2 (ja) * 2017-01-24 2021-11-17 株式会社スタージェン 神経変性疾患の改善用医薬

Similar Documents

Publication Publication Date Title
Lew et al. Discovery and development of GS 4104 (oseltamivir) an orally active influenza neuraminidase inhibitor
JP2024160287A5 (https=)
ITMI20101459A1 (it) Composizione comprendente glutatione reduttasi e glutatione ossidato
TW577744B (en) Medicinal compositions containing 3,6-anhydrogalactopyranose as active ingredient
JP2008542237A5 (https=)
CN113995744B (zh) 一种组合物及其抗菌应用
JP2022062153A5 (https=)
EP3360547B1 (en) Bactericidal pharmaceutical composition comprising ibuprofen
JPWO2023132372A5 (https=)
JP2021513521A5 (https=)
HU225600B1 (en) Liquid compositions comprising lamivudine
WO2017223178A1 (en) Treating viral infections with impdh inhibitors
JP2009522257A (ja) ウイルス感染症治療用薬剤
KR20150126382A (ko) 위 내의 알데하이드에 결합하는 캡슐화된 조성물
TW202214237A (zh) 伐達司他之藥物－藥物交互作用的調節
JP3228534B2 (ja) 血中アルコール濃度低下用組成物
JP2024056100A5 (https=)
JP2010523506A5 (https=)
Mahapatra et al. Potential activity of nanomaterials to combat SARS-CoV-2 and mucormycosis‎ coinfection‎
CN104083360B (zh) 一种用于制备抗曲霉菌药物的中药组合物
CA3022391A1 (en) Methods for the treatment of infection
CN101583378A (zh) 抗微生物的萜组合物
Guthappa Docking studies of usnic acid and sodium usnate on SARS CoV-2 main protease and spike protein RBD
JP2009507915A (ja) 抗菌剤としてのアミン−ボラン化合物の使用
CA2990298C (en) Agents for the treatment of retroviral infectious diseases